Sirius Genomics this week announced the promotion of Chris Wagner as its president and CEO. Wagner, previously VP of business development at Sirius, will replace Brad Popovich.
Before joining Sirius two years ago, Wagner was VP of marketing and VP of business development at Aspreva. He also held various positions at Eli Lilly.
Popovich will continue as a member of Sirius's board of directors.